APOLLOHOSPNSEQ4 FY 202226 May 2022

Apollo Hospitals Enterprise Limited

3,383words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
onment. • Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company
24%
Performance Q4 FY22        Q4 FY22 Consolidated Revenues of ` 35,464 mio (growth of 24% yoy). Q4 FY22 Consolidated EBITDA (Post Ind AS 116) of ` 4,632 mio. New Hospitals (excl Proton) r
58%
PBT in Q4FY22 to the extent of ` 119 mio.  Q4FY22 occupancy across the group was at 4,604 beds (58% occupancy) as compared to 4,631 beds (63% occupancy) in Q4FY21. The Key Operational Highlights Q
63%
 Q4FY22 occupancy across the group was at 4,604 beds (58% occupancy) as compared to 4,631 beds (63% occupancy) in Q4FY21. The Key Operational Highlights Q4 FY22   Q4FY22 occupancy in mature h
60%
Key Operational Highlights Q4 FY22   Q4FY22 occupancy in mature hospitals was at 3,284 beds (60% occupancy). New hospitals had an occupancy of 1,320 beds (55%) occupancy) in Q4FY22. Inpatient Vo
55%
n mature hospitals was at 3,284 beds (60% occupancy). New hospitals had an occupancy of 1,320 beds (55%) occupancy) in Q4FY22. Inpatient Volumes across the group increased by 7% from 108,169 to 115,902
7%
cupancy of 1,320 beds (55%) occupancy) in Q4FY22. Inpatient Volumes across the group increased by 7% from 108,169 to 115,902. ARPOB (excluding vaccination) was at ` 48,510 Vs ` 43,239 registering a g
12%
,169 to 115,902. ARPOB (excluding vaccination) was at ` 48,510 Vs ` 43,239 registering a growth of 12% in Q4 FY22 as compared to the same period previous year. Effective March 16, 2022, Pharmacy distr
100%
ctive March 16, 2022, Pharmacy distribution segment has been transferred to Apollo Health Co Ltd, a 100% subsidiary of AHEL. The Standalone P&L and results of the company hence do not present a full view
1.5 million
ai OMR Road to design and build a state-of-art advanced integrated health and wellness complex of 1.5 million sq.ft. The facility will be designed keeping in mind the next frontier of care delivery in healthc
3 lakh
services Digital healthcare app Apollo 24/7 – agile and digitally connected to the consumer, over 3 lakh digital consults during the Quarter. 7 CONSOLIDATED FINANCIAL PERFORMANCE CONSOLIDATED FINANCI
Rs 88
siness Combination in Q1FY22. #Capital Gain tax arising out of Health Co reorganization, amounts to Rs 88 crs (vide IND AS 103 Business combination). No cash outflow to the company as adjusted against MAT
Guidance — 1 items
Notes
opening
Post external capital raise at AHL, • • • • AHEL expected to retain dominant majority shareholding in AHL; and Slump sale consideration of INR Rs 1,210 crs will be received by AHEL.
Advertisement
Speaking time
Notes
1
Opening remarks
Notes
(1) Tamilnadu region includes Chennai hospitals, Madurai, Karur, Karaikudi, Trichy & Nellore. (2) AP, Telangana Region includes Hyderabad, Karimnagar, Vizag old, Vizag new & Kakinada. (3) Karnataka region includes Bangalore, Mysore, Jayanagar & Malleswaram. (4) Others include Bhubaneswar, Bilaspur, Nashik & Navi Mumbai. (5)Significant Hospital JVs/Subs/Associates are – Ahmedabad, Kolkata, Delhi, Indore, Assam & Lucknow (full revenues shown in table above). (6)Revenues under the head “Total” have not been provided as Consolidated actual results will differ from total due to proportionate consolidation. (7)Outpatient volume represents New Registrations only. (8)Revenues under Ind AS have been grossed up for Fixed fee Doctors & considered separately as operating cost. This was earlier being netted off from Revenues under Indian GAAP. ARPOB excludes Vaccination Revenue ParticularsFY 21FY 22 yoy (%)FY 21FY 22 yoy (%)FY 21FY 22 yoy (%)FY 21FY 22 yoy (%)FY 21FY 22 yoy (%)FY 21FY 22 yoy (%)No.
Advertisement
← All transcriptsAPOLLOHOSP stock page →